TOTatsuo Okui

Tatsuo Okui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tatsuo Okui has a total of 201 co-authors. Here are the top co-authors by number of shared publications:

  • Tsuyoshi Shimo

    Division of Reconstructive Surgery for Oral and Maxillofacial Region, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sciences University of Hokkaido, Hokkaido 061-0293, Japan

    18 shared publications
  • Akira Sasaki

    Department of Oral and Maxillofacial Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2‑5‑1 Shikata‑cho, Okayama, Okayama 700‑8525, Japan

    17 shared publications
  • Soichiro Ibaragi

    Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

    16 shared publications
  • Takahiro Kanno

    Department of Oral and Maxillofacial Surgery, Shimane University Faculty of Medicine, Izumo, Japan

    15 shared publications
  • Soichiro Ibaragi

    Department of Oral and Maxillofacial Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2‑5‑1 Shikata‑cho, Okayama, Okayama 700‑8525, Japan

    9 shared publications
  • Naito Kurio

    Department of Oral and Maxillofacial Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

    8 shared publications

Latest Publications

  • Parathyroid Hormone-related Peptide Promotes Cancer-induced Bone Pain Through Direct Sensory Neuron Activation and Osteoclast-mediated Mechanisms

    by Yodai Hayashi, Yusaku Noma, Haruka Yoshinaga, Ryota Takaoka, Yusei Yanagita, Shiori Kyoda, Yukie Noguchi, Kouta Yamashiro, Kazuaki Hasegawa, Toshiyuki Yoneda, et al.

    Breast, prostate, and head and neck cancers readily metastasize to the bone, often causing cancer-induced bone pain (CIBP). Osteoclast activation acidifies the tumor microenvironment, contributing to CIBP. This acidity is linked to parathyroid hormone-related peptide (PTHrP) produced by cancer cells. PTHrP upregulates acid-sensitive receptors in sensory neurons, but the underlying mechanisms remain unclear. We evaluated breast cancer-induced bone pain (BCIBP) in vitro using primary dorsal root ganglion (DRG) neurons and F11 neurons and in vivo using female C57BL/6 athymic nude mice injected with 4T1 breast cancer cells into the tibial bone marrow. Female C57BL/6 athymic nude mice developed BCIBP, characterized by upregulated phosphorylated ERK1/2 (pERK1/2) and phosphorylated CREB (pCREB) in DRG neurons, molecular indicators of neuronal excitation. Treatment with PTHrP (7-34), a PTHrP antagonist, suppressed BCIBP, pERK1/2, and pCREB expression in the DRG of 4T1-injected mice, tibial osteoclast differentiation, and secondary bone-to-lung metastasis. The PTHrP antagonist inhibited BCIBP indirectly by suppressing osteoclasts. PTHrP not only promoted osteoclast-mediated bone destruction but also directly induced bone pain by acting on sensory neurons.

  • Bisphosphonate Suppresses the Epithelial–Mesenchymal Transition of Post‐Tooth Extraction Oral Epithelial Cells via Direct and Indirect Pathways

    by Hiroshi Hijioka, Tatsuo Okui, Kazuaki Hasegawa, Kisho Ono, Takahiro Kanno, Kouta Yamashiro, Yusaku Noma, Ryota Takaoka, Keitaro Nishi, Toshiyuki Yoneda

    Purpose: Bisphosphonate‐related osteonecrosis of the jaw is thought to be caused by inhibition of osteoclasts, but according to recent research, it has become known that bisphosphonates affect not only osteoclasts but also immune cells and other cells. However, the direct effects of bisphosphonates on the immune system of the mucous membrane covering the bone and oral tissue are not clear. Methods: Using oral mucosal cell lines, we observed the effects of TGF‐β released from bone due to osteoclast‐mediated bone resorption during tooth extraction on oral mucosal cells in vivo and in vitro. These growth factors promote epithelial–mesenchymal transition (EMT) in oral mucosal cells and induce healing of the extraction site. Results: TGF‐β is released from bone due to osteoclast‐mediated bone resorption, but bisphosphonates inhibit osteoclast activity, thereby potentially indirectly inhibiting EMT by blocking the activity of the Smad pathway, a downstream target of TGF‐β signaling. Additionally, bisphosphonates increase the expression of the autophagy marker Beclin, suggesting the influence of autophagy on bone metabolism. Conclusion: In this study, administering bisphosphonate agents during tooth extraction, particularly during osteoporosis treatment, may prevent the onset of BRONJ by temporarily increasing local TGF‐β levels.

  • Open Access

    Association between malnutrition and low tongue pressure in community-dwelling older people: a population-based cohort study

    by Ryota Takaoka, Keitaro Nishi, Maya Nakamura, Haruka Yoshinaga, Yusaku Noma, Yodai Hayashi, Sayaka Yuda, Yumiko Mishima, Momoko Ishikawa, Yusei Yanagita, et al.

    The aim of this study was to analyze the data from a cohort study of community-dwelling older people to clarify the impact of low tongue pressure on the onset of malnutrition. The analysis was divided into a baseline and a longitudinal analysis. The baseline analysis included 765 people (median age: 74 years; 276 men and 489 women), and the longitudinal analysis included 100 people (median age: 72 years; 33 men and 67 women). The baseline analysis showed that tongue pressure and the diagnosis of low tongue pressure using a cut-off of 30 kPa were associated with the risk of malnutrition (tongue pressure: odds ratio [OR] = 0.972, 95% confidence interval [95% CI] = 0.953–0.992, p = 0.006; the diagnosis of low tongue pressure: OR = 1.555, 95% CI = 1.050–2.302, p = 0.027). In the longitudinal analysis, tongue pressure and the diagnosis of low tongue pressure at baseline were associated with the onset of the risk of malnutrition after 4 years (tongue pressure: OR = 0.952, 95% CI = 0.907–0.998, p = 0.041; the diagnosis of low tongue pressure: OR = 2.698, 95% CI = 1.148–6.341; p = 0.023). In community-dwelling older people, low tongue pressure could increase the risk of future malnutrition.


  • Open Access

    Association Between Cognitive Impairment and Poor Oral Function in Community-Dwelling Older People: A Cross-Sectional Study

    by Yumiko Mishima, Maya Nakamura, Yuhei Matsuda, Keitaro Nishi, Ryota Takaoka, Takahiro Kanno, Toshihiro Takenaka, Takayuki Tabira, Hyuma Makizako, Takuro Kubozono, et al.

    Background/Objectives: The population of Japan has a high life expectancy, but there is room for improvement in terms of the country’s healthy life expectancy. The long period of care dependency among Japan’s elderly is also a major economic health challenge. Dementia is a major factor in the need for care, and its prevention is a crucial and urgent challenge. There are recent reports of a possible association between changes in oral function and cognitive impairment, but the details of this association remain unclear. To clarify the relationship between poor oral function and cognitive impairment, we conducted an exploratory investigation using a cognitive function assessment (Mini-Cog) administered in a large-scale study and its relevance to oral function. Methods: The study population was 678 community-dwelling individuals aged ≥65 years living in Tarumizu city, Japan, in 2019. Cognitive function was assessed using the Mini-Cog test, and the oral survey was a modification of the content of the Oral Hypofunction Examination as defined by the Japanese Society of Gerodontology. Results: The participants’ median age was 73 years. The oral function results revealed median scores below the oral hypofunction criterion for occlusal force, tongue pressure, oral diadochokinesis, and swallowing function. The results of a binomial logistic regression analysis indicated that tongue–lip motor function was independently associated with oral function in relation to cognitive impairment. Conclusions: The oral function associated with cognitive impairment in this study was tongue–lip motor function. Aiming to improve this function may prevent the exacerbation of cognitive impairment.


  • Open Access

    Melting curve analyses in the quantitative real-time polymerase chain reaction of methylated/non-methylated DNA toward the detection of oral cancer using gargle fluid

    by Yusaku Noma, Hayate Sawayama, Kouta Yamashiro, Keitaro Nishi, Haruka Yoshinaga, Ryota Takaoka, Tsuyoshi Sugiura, Tomonori Sasahira, Tomofumi Hamada, Yasuo Suda, et al.

  • Open Access

    Feasibility of navigation-assisted endoscopic transnasal optic nerve decompression for the treatment of traumatic optic neuropathy in patients with midfacial fractures

    by Taro Okui, Tatsunori Sakamoto, Ichiro Morikura, Tatsuo Okui, Kentaro Ayasaka, Satoe Okuma, Hiroto Tatsumi, Takahiro Kanno

    Taro Okui, Tatsunori Sakamoto, Ichiro Morikura, Tatsuo Okui, Kentaro Ayasaka, Satoe Okuma, Hiroto Tatsumi, Takahiro Kanno. JKAOMS 2024;50:273-84. https://doi.org/10.5125/jkaoms.2024.50.5.273


  • Open Access

    Novel mechanism of cisplatin resistance in head and neck squamous cell carcinoma involving extracellular vesicles and a copper transporter system

    by Tatsuo Ogawa, Kisho Ono, Shoji Ryumon, Hotaka Kawai, Tomoya Nakamura, Koki Umemori, Kunihiro Yoshida, Hideka Kanemoto, Kyoichi Obata, Norie Yoshioka, et al.

    BackgroundCisplatin (CDDP) plays a central role in chemotherapy for head and neck squamous cell carcinoma (HNSCC), but drug resistance in HNSCC chemotherapy remains a problem, and the mechanism of CDDP resistance is unclear. We investigated CDDP-resistance mechanisms mediated by extracellular vesicles (EVs) and ATPase copper transporting beta (ATP7B) in HNSCC.MethodsWe established CDDP-resistant sublines of HNSCC cells and verified their ATP7B expression. We used an EV secretion inhibitor (GW4869) and ATP7B short hairpin (sh)RNA transfection to examine the correlation between EV secretion and ATP7B expression.ResultsThe CDDP-resistant HNSCC sublines showed decreased CDDP sensitivity and increased ATP7B expression. GW4869 suppressed ATP7B expression, and ATP7B shRNA transfection suppressed EV secretion. The suppressions of EV secretion and ATP7B expression both enhanced CDDP's cell-killing effect.ConclusionsEVs were involved in the ATP7B-mediated mechanism underlying CDDP resistance. Further clarification of the EV-induced CDDP-resistance mechanism may lead to novel therapeutic strategies for HNSCC.


  • Open Access

    In Vivo Evaluation of Bone Regenerative Capacity of the Novel Nanobiomaterial: β-Tricalcium Phosphate Polylactic Acid-co-Glycolide (β-TCP/PLLA/PGA) for Use in Maxillofacial Bone Defects

    by Mrunalini Ramanathan, Ankhtsetseg Shijirbold, Tatsuo Okui, Hiroto Tatsumi, Tatsuhito Kotani, Yukiho Shimamura, Reon Morioka, Kentaro Ayasaka, Takahiro Kanno

    Maxillofacial bone defects are treated by autografting or filling with synthetic materials in various forms and shapes. Electrospun nanobiomaterials are becoming popular due to their easy placement and handling; combining ideal biomaterials extrapolates better outcomes. We used a novel electrospun cotton-like fiber made from two time-tested bioresorbable materials, β-TCP and PLLA/PGA, to check the feasibility of its application to maxillofacial bone defects through an in vivo rat mandibular bone defect model. Novel β-TCP/PLLA/PGA and pure β-TCP blocks were evaluated for new bone regeneration through assessment of bone volume, inner defect diameter reduction, and bone mineral density. Bioactive/osteoconductivity was checked by scoring the levels of Runt-related transcription factor x, Leptin Receptor, Osteocalcin, and Periostin biomarkers. Bone regeneration in both β-TCP/PLLA/PGA and β-TCP was comparable at initial timepoints. Osteogenic cell accumulation was greater in β-TCP/PLLA/PGA than in β-TCP at initial as well as late phases. Periostin expression was more marked in β-TCP/PLLA/PGA. This study demonstrated comparable results between β-TCP/PLLA/PGA and β-TCP in terms of bone regeneration and bioactivity, even with a small material volume of β-TCP/PLLA/PGA and a decreased percentage of β-TCP. Electrospun β-TCP/PLLA/PGA is an ideal nanobiomaterial for inducing bone regeneration through osteoconductivity and bioresorbability in bony defects of the maxillofacial region.


  • Open Access

    Evaluation of Hard and Soft Tissue Responses to Four Different Generation Bioresorbable Materials-Poly-l-Lactic Acid (PLLA), Poly-l-Lactic Acid/Polyglycolic Acid (PLLA/PGA), Uncalcined/Unsintered Hydroxyapatite/Poly-l-Lactic Acid (u-HA/PLLA) and Uncalcined/Unsintered Hydroxyapatite/Poly-l-Lactic Acid/Polyglycolic Acid (u-HA/PLLA/PGA) in Maxillofacial Surgery: An In-Vivo Animal Study

    by Kentaro Ayasaka, Mrunalini Ramanathan, Ngo Xuan Huy, Ankhtsetseg Shijirbold, Tatsuo Okui, Hiroto Tatsumi, Tatsuhito Kotani, Yukiho Shimamura, Reon Morioka, Takahiro Kanno

    Bone stabilization using osteosynthesis devices is essential in maxillofacial surgery. Owing to numerous disadvantages, bioresorbable materials are preferred over titanium for osteofixation in certain procedures. The biomaterials used for osteosynthesis in maxillofacial surgery have been subdivided into four generations. No study has compared the tissue responses generated by four generations of biomaterials and the feasibility of using these biomaterials in different maxillofacial surgeries. We conducted an in vivo animal study to evaluate host tissue response to four generations of implanted biomaterial sheets, namely, PLLA, PLLA/PGA, u-HA/PLLA, and u-HA/PLLA/PGA. New bone volume and pertinent biomarkers for bone regeneration, such as Runx2, osteocalcin (OCN), and the inflammatory marker CD68, were analyzed, and the expression of each biomarker was correlated with soft tissues outside the biomaterial and toward the host bone at the end of week 2 and week 10. The use of first-generation biomaterials for maxillofacial osteosynthesis is not advantageous over the use of other updated biomaterials. Second-generation biomaterials degrade faster and can be potentially used in non-stress regions, such as the midface. Third and fourth-generation biomaterials possess bioactive/osteoconductivity improved strength. Application of third-generation biomaterials can be considered panfacially. Fourth-generation biomaterials can be worth considering applying at midface due to the shorter degradation period.